Compound Detail
CHEMBL465123
SEPROXETINE 🧪 Phase II
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
🧪 Phase II
Basic Information
| ChEMBL ID | CHEMBL465123 |
| Name | SEPROXETINE |
| Phase | Phase II |
| Structure Type | MOL |
| InChI Key | WIQRCHMSJFFONW-HNNXBMFYSA-N |
3
Targets
6
Activities
2
Assay Types
0
PK Parameters
6
Publications
4
Known Names
Molecular Properties
295.3
MW (Da)
4.17
ALogP
2
HBA
1
HBD
35.2
PSA (Ų)
0.90
QED
0
Ro5 Violations
5
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Chirality | Single Enantiomer |
Activity Summary
IC50 3 meas. best 7.34
Ki 3 meas. best 7.3
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Sodium-dependent serotonin transporter CHEMBL228 | IC50 | 7.34 | 7.34 | 46.0 | 1 |
| Sodium-dependent serotonin transporter CHEMBL228 | Ki | 7.3 | 7.3 | 50.0 | 1 |
| Sodium-dependent noradrenaline transporter CHEMBL222 | IC50 | 5.55 | 5.55 | 2806.0 | 1 |
| Sodium-dependent dopamine transporter CHEMBL238 | Ki | 5.34 | 5.34 | 4544.0 | 1 |
| Sodium-dependent noradrenaline transporter CHEMBL222 | Ki | 5.21 | 5.21 | 6186.0 | 1 |
| Sodium-dependent dopamine transporter CHEMBL238 | IC50 | 5.19 | 5.19 | 6488.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Sodium-dependent serotonin transporter | IC50 | = | 46.0 | nM | 7.34 | Inhibition of [3H]5HT from human recombinant SERT expressed in HEK293 cells | 19014888 |
| Sodium-dependent serotonin transporter | Ki | = | 50.0 | nM | 7.3 | Displacement of [125I]RTI55 from human recombinant SERT expressed in HEK293 cell... | 19014888 |
| Sodium-dependent noradrenaline transporter | IC50 | = | 2806.0 | nM | 5.55 | Inhibition of [3H]NE from human recombinant NET expressed in HEK293 cells | 19014888 |
| Sodium-dependent dopamine transporter | Ki | = | 4544.0 | nM | 5.34 | Displacement of [125I]RTI55 from human recombinant DAT expressed in HEK293 cells | 19014888 |
| Sodium-dependent noradrenaline transporter | Ki | = | 6186.0 | nM | 5.21 | Displacement of [125I]RTI55 from human recombinant NET expressed in HEK293 cells | 19014888 |
| Sodium-dependent dopamine transporter | IC50 | = | 6488.0 | nM | 5.19 | Inhibition of [3H]DA from human recombinant DAT expressed in HEK293 cells | 19014888 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| - | 10.6019/CHEMBL4651402 | SARS-CoV-2 | 4 |
| 19014888 | 10.1016/j.bmc.2008.10.065 | Sodium-dependent dopamine transporter | 2 |
| 19014888 | 10.1016/j.bmc.2008.10.065 | Sodium-dependent serotonin transporter | 2 |
| 19014888 | 10.1016/j.bmc.2008.10.065 | Sodium-dependent noradrenaline transporter | 2 |
| - | 10.6019/CHEMBL4651402 | Vero C1008 | 2 |
| 19014888 | 10.1016/j.bmc.2008.10.065 | 3',5'-cyclic-AMP phosphodiesterase 4D | 1 |
Data from ChEMBL 36 via Core Engine